한글목차

세계 신경가소성 치료 시장 전망은 유망하며, 만성통증, 양안시, 뇌손상 치료 및 기타 시장에서의 기회가 기대되고 있습니다. 세계 신경가소성 치료 시장은 2025-2031년 연평균 3.5%의 성장률을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 신경 질환의 유병률 증가와 신경 가소성 기반 치료의 발전, 뇌 손상 및 재활을 위한 개인 맞춤형 치료의 채택 증가, 조기 개입 및 예방에 대한 관심 증가 등입니다.

• Lucintel은 유형별로는 기능적 신경가소성이 예측 기간 동안 높은 성장세를 보일 것으로 전망하고 있습니다.
• 용도별로는 뇌손상 치료가 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장을 보일 것으로 예측됩니다.

신경가소성 치료 시장의 새로운 트렌드

신경가소성 치료 시장은 기술 혁신과 개인 맞춤형 치료에 대한 환자 수요 증가로 빠르게 발전하고 있습니다. 주요 동향으로는 뇌 자극 기술의 발전, 인공지능의 통합, 디지털 치료법의 부상 등이 있으며, 이 모든 것이 인지 재활의 상황을 재구성하고 있습니다.

• 뇌 자극 기술: 경두개 자기자극법(TMS)이나 경두개 직류 전류 자극법(tDCS)과 같은 비침습적 기술은 뇌 부위를 자극해 신경 가소성을 높이는 효과가 있어 각광받고 있습니다. 이러한 기술은 뇌졸중 재활, 우울증 치료, 인지 장애 등에 점점 더 많이 사용되고 있습니다.
• AI를 활용한 신경가소성 솔루션: 인공지능은 뇌 활동과 환자의 데이터를 분석하여 개인화된 치료 프로토콜을 만드는 데 활용되고 있습니다. AI를 활용한 솔루션은 보다 정확하고 적응력이 높은 치료를 가능하게 하여 회복 과정을 최적화하고 임상 결과를 개선할 수 있습니다.
• 디지털 치료제와 모바일 앱: 모바일 앱과 VR 기반 프로그램을 포함한 디지털 치료는 환자가 집에서 인지 운동을 할 수 있는 능력을 제공함으로써 신경가소성 치료에 혁명을 일으키고 있습니다. 이러한 플랫폼은 특히 의료서비스가 부족한 지역에서 치료를 더 쉽게 이용할 수 있고, 비용 효율적이며, 확장성이 높습니다.
• 가상현실(VR) 통합: VR 기술은 특히 뇌졸중 및 외상성 뇌손상(TBI) 환자를 위한 신경가소성 치료에 통합되고 있습니다. VR을 활용한 재활 프로그램은 환자를 인지 능력과 운동 능력에 도전하는 시뮬레이션 환경으로 끌어들여 신경가소성 성과를 향상시킵니다.
• 조기 개입과 예방의 중요성: 특히 알츠하이머병, 파킨슨병과 같은 신경퇴행성 질환에서 신경가소성에 기반한 치료법의 조기 개입과 예방의학이 중요시되고 있습니다. 초기 단계의 치료법은 뇌 기능을 강화하고, 이러한 질병의 진행을 늦추고, 환자의 장기적인 결과를 개선하도록 설계되었습니다.

이러한 새로운 트렌드는 다양한 신경질환에 대해 보다 접근성이 높고 효과적인 맞춤형 치료를 제공함으로써 신경가소성 치료 시장을 변화시키고 있습니다. 뇌 자극, AI, VR, 디지털 치료제의 조합은 인지 재활에 대한 보다 종합적인 접근을 통해 환자에게 회복을 위한 여러 경로를 제공합니다. 또한, 조기 개입과 예방에 대한 관심이 높아지면서 신경가소성 치료는 주류 의료의 중요한 부분이 될 것이며, 향후 몇 년 동안 시장이 크게 확대될 가능성이 높습니다.

신경가소성 치료 시장의 최근 동향

신경가소성 치료 시장은 기술, 임상 응용 및 규제 프레임워크의 괄목할 만한 발전으로 빠르게 발전하고 있습니다. 주요 진전 사항으로는 AI 기반 치료의 통합, 뇌 자극 기술 채택 확대, 인지 재활을 위한 디지털 플랫폼의 부상 등이 있습니다.

• AI 기반 개인 맞춤형 치료 프로토콜: AI는 신경가소성 치료를 환자 개개인의 필요에 맞게 조정하고, 치료 결과를 최적화하기 위해 활용되고 있습니다. AI는 뇌 활동, 인지 테스트, 환자 데이터를 분석하여 보다 타겟팅된 치료를 가능하게 하고, 회복 시간을 단축하고 뇌 기능을 향상시킬 수 있습니다.
• 뇌 자극 기술의 확장: TMS와 tDCS와 같은 비침습적 뇌 자극 기술은 뇌졸중 회복에서 기분 장애에 이르기까지 다양한 신경 질환의 치료에 점점 더 많이 사용되고 있습니다. 이러한 치료법은 특정 뇌 부위를 자극하여 신경 결합을 촉진하고 회복을 촉진합니다.
• 인지 재활을 위한 디지털 플랫폼의 부상: 인지 재활을 위한 모바일 앱과 가상현실 프로그램의 이용이 빠르게 증가하고 있습니다. 이러한 디지털 도구는 특히 원격지나 대면 진료가 어려운 환자들에게 신경가소성 치료를 보다 쉽고, 비용 효율적이며, 편리하게 이용할 수 있게 해줍니다.
• 공동연구개발: 학계, 하이테크 기업, 의료진 간의 협력관계 강화로 혁신적인 신경가소성 치료법 개발이 가속화되고 있습니다. 이러한 파트너십은 신경 재활의 획기적인 발전을 촉진하고 뇌의 회복을 촉진하는 새로운 치료법의 창출을 촉진하고 있습니다.
• 새로운 치료법의 약사 승인: 여러 지역에서 여러 가지 새로운 신경가소성 치료법이 규제 당국의 승인을 받아 혁신적인 치료법의 가용성이 확대되고 있습니다. 규제 당국은 비침습적 치료법의 효능을 인정하고 있으며, 임상 현장에서 폭넓게 채택될 수 있는 길을 열어주고 있습니다.

이러한 개발은 치료의 접근성, 개별화, 효과성을 향상시켜 신경가소성 치료 시장의 성장을 크게 가속화하고 있습니다. AI, 디지털 플랫폼, 첨단 뇌 자극 기술의 활용은 보다 정밀한 치료를 가능하게 하고, 회복 시간을 단축하며, 치료할 수 있는 증상의 범위를 넓히고 있습니다. 이러한 치료법이 규제 당국에 의해 널리 수용됨에 따라 시장은 더욱 성장할 것이며, 신경가소성 중재가 의료의 주류가 될 가능성이 높습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 신경가소성 치료 시장 : 유형별

• 개요
• 매력 분석 : 유형별
• 구조적 신경가소성 : 동향과 예측(2019-2031년)
• 기능적 신경가소성 : 동향과 예측(2019-2031년)

제5장 세계의 신경가소성 치료 시장 : 용도별

• 개요
• 매력 분석 : 용도별
• 만성 통증 : 동향과 예측(2019-2031년)
• 양안 시력 : 동향과 예측(2019-2031년)
• 뇌손상 치료 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 세계의 신경가소성 치료 시장 : 지역별

제7장 북미의 신경가소성 치료 시장

• 개요
• 미국의 신경가소성 치료 시장
• 멕시코의 신경가소성 치료 시장
• 캐나다의 신경가소성 치료 시장

제8장 유럽의 신경가소성 치료 시장

• 개요
• 독일의 신경가소성 치료 시장
• 프랑스의 신경가소성 치료 시장
• 스페인의 신경가소성 치료 시장
• 이탈리아의 신경가소성 치료 시장
• 영국의 신경가소성 치료 시장

제9장 아시아태평양의 신경가소성 치료 시장

• 개요
• 일본의 신경가소성 치료 시장
• 인도의 신경가소성 치료 시장
• 중국의 신경가소성 치료 시장
• 한국의 신경가소성 치료 시장
• 인도네시아의 신경가소성 치료 시장

제10장 기타 지역(ROW)의 신경가소성 치료 시장

• 개요
• 중동의 신경가소성 치료 시장
• 남미의 신경가소성 치료 시장
• 아프리카의 신경가소성 치료 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석
  • 경쟁 기업간 경쟁 관계
  • 바이어의 교섭력
  • 공급업체의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 성장 기회 : 유형별
  • 성장 기회 : 용도별
• 세계 신경가소성 치료 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증 및 라이선싱
  • 인수합병(M&A), 계약, 제휴 및 합작투자(JV)

제13장 밸류체인 주요 기업 개요

• 경쟁 분석
• Bionik
• Mindmed
• Nans Tech
• Sense Therapy
• IBT

제14장 부록

• 그림 리스트
• 표 리스트
• 분석 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• Lucintel에 대해
• 문의

영문목차

The future of the global neuroplasticity therapy market looks promising with opportunities in the chronic pain, binocular vision, treatment of brain damage, and other markets. The global neuroplasticity therapy market is expected to grow with a CAGR of 3.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of neurological disorders and advancements in neuroplasticity-based therapies, the increasing adoption of personalized treatments for brain injury and rehabilitation, and the focus on early intervention and prevention.

• Lucintel forecasts that, within the type category, functional neuroplasticity is expected to witness higher growth over the forecast period.
• Within the application category, treatment of brain damage is expected to witness the higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Neuroplasticity Therapy Market

The neuroplasticity therapy market is evolving rapidly, driven by technological innovation and growing patient demand for personalized treatments. Key trends include advancements in brain stimulation techniques, the integration of artificial intelligence, and the rise of digital therapeutics, all of which are reshaping the landscape of cognitive rehabilitation.

• Brain Stimulation Technologies: Non-invasive techniques like transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are gaining traction for their effectiveness in stimulating brain regions to enhance neuroplasticity. These techniques are increasingly used in stroke rehabilitation, depression treatment, and cognitive disorders.
• AI-Powered Neuroplasticity Solutions: Artificial intelligence is being used to create personalized therapy protocols by analyzing brain activity and patient data. AI-driven solutions enable more precise and adaptive treatments, optimizing recovery processes and improving clinical outcomes.
• Digital Therapeutics and Mobile Apps: Digital therapeutics, including mobile apps and VR-based programs, are revolutionizing neuroplasticity therapy by offering patients the ability to engage in cognitive exercises at home. These platforms make therapy more accessible, cost-effective, and scalable, especially in underserved regions.
• Integration of Virtual Reality (VR): VR technologies are being integrated into neuroplasticity therapies, particularly for stroke and traumatic brain injury (TBI) patients. VR-based rehabilitation programs engage patients in simulated environments that challenge cognitive and motor skills, improving neuroplasticity outcomes.
• Focus on Early Intervention and Prevention: There is a growing emphasis on early intervention and preventive care for neuroplasticity-based therapies, particularly in neurodegenerative diseases like Alzheimer's and Parkinson's. Early-stage therapies are designed to enhance brain function and slow the progression of these conditions, improving long-term patient outcomes.

These emerging trends are transforming the neuroplasticity therapy market by offering more accessible, personalized, and effective treatments for a wide range of neurological conditions. The combination of brain stimulation, AI, VR, and digital therapeutics is leading to a more holistic approach to cognitive rehabilitation, providing patients with multiple pathways for recovery. Additionally, the growing emphasis on early intervention and prevention is likely to significantly expand the market in the coming years, making neuroplasticity therapies a key part of mainstream healthcare.

Recent Developments in the Neuroplasticity Therapy Market

The neuroplasticity therapy market has been evolving rapidly with notable developments in technology, clinical applications, and regulatory frameworks. Key advances include the integration of AI-driven therapies, increased adoption of brain stimulation techniques, and the rise of digital platforms for cognitive rehabilitation.

• AI-Driven Personalized Therapy Protocols: AI is being used to tailor neuroplasticity treatments to individual patient needs, optimizing therapeutic outcomes. By analyzing brain activity, cognitive tests, and patient data, AI enables more targeted therapy, reducing recovery time and improving brain function.
• Expansion of Brain Stimulation Techniques: Non-invasive brain stimulation techniques like TMS and tDCS are being increasingly used to treat a wide range of neurological conditions, from stroke recovery to mood disorders. These therapies help promote neural connections and facilitate recovery by stimulating specific brain regions.
• Rise of Digital Platforms for Cognitive Rehabilitation: The use of mobile apps and virtual reality programs for cognitive rehabilitation is growing rapidly. These digital tools are making neuroplasticity therapy more accessible, cost-effective, and convenient for patients, particularly in remote areas or those with limited access to in-person care.
• Collaborative Research and Development: Increased collaboration between academic institutions, tech companies, and healthcare providers is accelerating the development of innovative neuroplasticity therapies. These partnerships are driving breakthroughs in neurorehabilitation and fostering the creation of new therapies that enhance brain recovery.
• Regulatory Approvals for New Therapies: Several new neuroplasticity therapies have received regulatory approval in various regions, expanding the availability of innovative treatments. Regulatory agencies are increasingly recognizing the effectiveness of non-invasive therapies, paving the way for wider adoption in clinical settings.

These developments are significantly accelerating the growth of the neuroplasticity therapy market by improving the accessibility, personalization, and effectiveness of treatments. The use of AI, digital platforms, and advanced brain stimulation techniques is enabling more targeted therapies, reducing recovery time, and expanding the range of treatable conditions. As these therapies receive wider regulatory acceptance, the market is likely to see further growth, bringing neuroplasticity interventions to mainstream healthcare.

Strategic Growth Opportunities in the Neuroplasticity Therapy Market

The neuroplasticity therapy market presents numerous growth opportunities across a range of applications, particularly in cognitive rehabilitation, mental health, and neurodegenerative diseases. The rise of digital health technologies and the increasing demand for personalized treatments are opening new avenues for expansion.

• Cognitive Rehabilitation for Stroke and TBI: There is significant growth potential in applying neuroplasticity therapies to stroke and traumatic brain injury (TBI) patients. Advanced therapies like VR and brain stimulation can accelerate recovery by promoting neural plasticity and restoring cognitive function.
• Treatment for Neurodegenerative Diseases: Neuroplasticity therapies are being increasingly explored for conditions like Alzheimer's and Parkinson's disease. Early-stage interventions can improve brain function and slow disease progression, presenting a major opportunity in the growing geriatric care market.
• Mental Health and Depression: Neuroplasticity therapies are also being used to treat mental health conditions such as depression, anxiety, and PTSD. By targeting specific brain regions, these therapies offer a non-pharmacological alternative, creating a growing market for mental health applications.
• Mobile Applications for At-Home Therapy: Mobile and digital platforms that deliver neuroplasticity-based therapies at home present significant growth potential. These platforms are making therapy more accessible, scalable, and affordable, especially for patients who do not have access to in-person sessions.
• Early Intervention in Pediatric Care: Neuroplasticity therapies are increasingly being used in early childhood to address developmental delays and cognitive impairments. This represents a growing market for therapies designed to enhance brain development and learning in young children.

These strategic growth opportunities are reshaping the neuroplasticity therapy market by expanding its reach to diverse patient populations and applications. From stroke recovery to mental health treatment and pediatric interventions, neuroplasticity therapies are becoming integral to modern healthcare. The rise of digital solutions and early-stage interventions is further broadening market access, making neuroplasticity therapies a more integral part of preventive and rehabilitative healthcare across the globe.

Neuroplasticity Therapy Market Driver and Challenges

The neuroplasticity therapy market is being driven by technological advancements, increased awareness of neurological disorders, and a growing demand for personalized, non-invasive treatments. However, challenges such as regulatory hurdles, high treatment costs, and the need for more clinical evidence remain significant obstacles to widespread adoption.

The factors responsible for driving the neuroplasticity therapy market include:

1. Technological Advancements in Brain Stimulation: New techniques in brain stimulation, such as TMS and tDCS, are allowing for more effective and targeted neuroplasticity therapies. These technologies have proven successful in treating a range of neurological conditions, from cognitive decline to mental health disorders.

2. Increasing Prevalence of Neurological Disorders: The rising incidence of neurological conditions like stroke, Alzheimer's, and Parkinson's is fueling demand for neuroplasticity therapies. As populations age, the need for effective rehabilitation and prevention treatments is growing, expanding the market.

3. Government and Private Funding: Increased investments in research and development, both from governments and private enterprises, are driving innovation in the neuroplasticity therapy space. Funding is helping accelerate the development of new therapies and solutions.

4. Growing Awareness and Acceptance of Non-Invasive Therapies: As patients and healthcare providers seek alternatives to invasive surgeries and medications, non-invasive neuroplasticity therapies are gaining acceptance. These therapies are seen as safer and more accessible options for long-term treatment.

5. Rising Demand for Personalized Medicine: The trend toward personalized medicine is boosting the adoption of neuroplasticity therapies. AI and data-driven solutions are being used to tailor therapies to individual patient needs, optimizing outcomes and improving recovery.

Challenges in the neuroplasticity therapy market are:

1. Regulatory Approval and Standardization: Regulatory hurdles remain a major challenge for new neuroplasticity therapies. Obtaining approvals for new treatments and establishing standard protocols for care are critical for market expansion and adoption.

2. High Treatment Costs: While neuroplasticity therapies are effective, their high costs can be prohibitive, particularly for patients in low-income regions. This limits market access and adoption, particularly in emerging economies.

3. Need for More Clinical Evidence: Despite growing interest, more rigorous clinical trials and evidence are needed to establish the long-term efficacy of many neuroplasticity therapies. The lack of robust clinical data may slow the acceptance and reimbursement of these therapies.

The neuroplasticity therapy market is experiencing rapid growth, driven by technological innovation, an aging population, and increasing demand for non-invasive treatments. While the market faces challenges related to regulatory approvals, cost, and clinical evidence, the potential for growth is substantial. The ongoing advancements in brain stimulation technologies, digital health, and personalized treatments are reshaping the landscape of cognitive rehabilitation, offering new hope for patients and expanding the market globally.

List of Neuroplasticity Therapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, neuroplasticity therapy companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neuroplasticity therapy companies profiled in this report include:

• Bionik
• Mindmed
• Nans Tech
• Sense Therapy
• IBT

Neuroplasticity Therapy Market by Segment

The study includes a forecast for the global neuroplasticity therapy market by type, application, and region.

Neuroplasticity Therapy Market by Type [Value from 2019 to 2031]:

• Structural Neuroplasticity
• Functional Neuroplasticity

Neuroplasticity Therapy Market by Application [Value from 2019 to 2031]:

• Chronic Pain
• Binocular Vision
• Treatment Of Brain Damage
• Others

Neuroplasticity Therapy Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Neuroplasticity Therapy Market

The neuroplasticity therapy market has witnessed significant advancements in recent years, driven by a growing understanding of brain adaptability and the application of innovative therapies. Key regions such as the United States, China, Germany, India, and Japan have seen substantial developments in both research and clinical applications of neuroplasticity therapies. These advancements include the use of non-invasive techniques, AI, and digital platforms to enhance brain recovery and cognitive function, offering new hope for patients with neurological disorders.

• United States: In the United States, the neuroplasticity therapy market is driven by ongoing clinical research and the integration of advanced technologies such as transcranial magnetic stimulation (TMS) and neurofeedback. The U.S. market has also seen significant growth in digital therapeutics, which offer at-home therapies for brain training. Public and private funding for neuroplasticity research, especially for post-stroke recovery and cognitive impairments, has increased, leading to the development of new therapies and more personalized treatment options for neurological patients.
• China: China's neuroplasticity therapy market is expanding due to the country's significant investments in healthcare innovation and a growing focus on mental health. Non-invasive therapies like transcranial direct current stimulation (tDCS) and neurofeedback are being increasingly adopted for cognitive rehabilitation. In addition, China is leveraging AI and big data to develop personalized neuroplasticity therapy protocols. With a large aging population and a rising incidence of neurological diseases, the demand for neuroplasticity therapies is expected to continue growing.
• Germany: Germany is at the forefront of neuroplasticity therapy development in Europe, with a strong emphasis on research and the integration of advanced technologies in clinical settings. Neurorehabilitation centers are adopting techniques such as robotic therapy and brain-computer interfaces (BCIs) to enhance neuroplasticity. The country's healthcare system supports innovation in non-invasive therapies, particularly for stroke recovery and dementia. Collaborative research between universities, tech companies, and healthcare providers is helping drive the growth of the market.
• India: In India, the neuroplasticity therapy market is gaining momentum, particularly in urban centers where awareness of neurological disorders is on the rise. There is increasing adoption of cognitive rehabilitation therapies using VR, neurofeedback, and digital platforms. India is also seeing the rise of specialized clinics and startups offering neuroplasticity-based treatments for conditions such as stroke, Parkinson's disease, and developmental disorders. Affordability and access to these therapies remain challenges, but the demand for affordable neuroplasticity solutions is driving growth.
• Japan: Japan is a leader in the development of neuroplasticity therapies, particularly for aging populations. The country has pioneered the use of brain stimulation techniques, such as tDCS and repetitive transcranial magnetic stimulation (rTMS), to treat cognitive decline and improve motor function in stroke and Alzheimer's patients. Japan's healthcare system has embraced technology-driven solutions, including AI-based brain training programs and robotic rehabilitation devices, to accelerate neuroplastic recovery, making neuroplasticity therapy more accessible and effective for patients.

Features of the Global Neuroplasticity Therapy Market

• Market Size Estimates: Neuroplasticity therapy market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Neuroplasticity therapy market size by type, application, and region in terms of value ($B).
• Regional Analysis: Neuroplasticity therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the neuroplasticity therapy market.
• Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the neuroplasticity therapy market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the neuroplasticity therapy market by type (structural neuroplasticity and functional neuroplasticity), application (chronic pain, binocular vision, treatment of brain damage, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Neuroplasticity Therapy Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Structural Neuroplasticity: Trends and Forecast (2019-2031)
• 4.4 Functional Neuroplasticity: Trends and Forecast (2019-2031)

5. Global Neuroplasticity Therapy Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Chronic Pain: Trends and Forecast (2019-2031)
• 5.4 Binocular Vision: Trends and Forecast (2019-2031)
• 5.5 Treatment of Brain Damage: Trends and Forecast (2019-2031)
• 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Neuroplasticity Therapy Market by Region

7. North American Neuroplasticity Therapy Market

• 7.1 Overview
• 7.4 United States Neuroplasticity Therapy Market
• 7.5 Mexican Neuroplasticity Therapy Market
• 7.6 Canadian Neuroplasticity Therapy Market

8. European Neuroplasticity Therapy Market

• 8.1 Overview
• 8.4 German Neuroplasticity Therapy Market
• 8.5 French Neuroplasticity Therapy Market
• 8.6 Spanish Neuroplasticity Therapy Market
• 8.7 Italian Neuroplasticity Therapy Market
• 8.8 United Kingdom Neuroplasticity Therapy Market

9. APAC Neuroplasticity Therapy Market

• 9.1 Overview
• 9.4 Japanese Neuroplasticity Therapy Market
• 9.5 Indian Neuroplasticity Therapy Market
• 9.6 Chinese Neuroplasticity Therapy Market
• 9.7 South Korean Neuroplasticity Therapy Market
• 9.8 Indonesian Neuroplasticity Therapy Market

10. ROW Neuroplasticity Therapy Market

• 10.1 Overview
• 10.4 Middle Eastern Neuroplasticity Therapy Market
• 10.5 South American Neuroplasticity Therapy Market
• 10.6 African Neuroplasticity Therapy Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Neuroplasticity Therapy Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Bionik
  • Company Overview
  • Neuroplasticity Therapy Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Mindmed
  • Company Overview
  • Neuroplasticity Therapy Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Nans Tech
  • Company Overview
  • Neuroplasticity Therapy Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Sense Therapy
  • Company Overview
  • Neuroplasticity Therapy Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 IBT
  • Company Overview
  • Neuroplasticity Therapy Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us